Anti-tumor necrosis factor therapy in patients with difficult to treat Takayasu arteritis

Arthritis and Rheumatism
Gary S HoffmanPatrick Liang

Abstract

Granulomatous inflammation is a typical feature of Takayasu arteritis (TA), and tumor necrosis factor (TNF) is important in the formation of granulomas. In this study, we assessed therapy with anti-TNF agents in patients with TA that was not controlled by glucocorticoid therapy or other immunosuppressants. We conducted an open-label trial of anti-TNF therapy at 3 academic medical centers over a period of 4.25 years. Fifteen patients with active, relapsing TA (median 6 years) were selected. Seven received etanercept (later changed to infliximab in 3 patients), and 8 received infliximab. Relapses had occurred in all patients while they were receiving glucocorticoids and, in 13 patients, additional immunosuppressive drugs. No other agents were added to the treatment regimen concurrently with anti-TNF. If patients were receiving cytotoxic agents, the dosage was not increased. Clinical symptoms were recorded, and physical examinations, laboratory studies, and serial magnetic resonance imaging were performed. The median daily dose of prednisone required to maintain remission prior to anti-TNF therapy was 20 mg. Ten of the 15 patients achieved complete remission that was sustained for 1-3.3 years without glucocorticoid therapy. Four p...Continue Reading

Associated Clinical Trials

References

Jun 1, 1994·Annals of Internal Medicine·G S KerrG S Hoffman
Oct 30, 2003·Annals of the Rheumatic Diseases·A P AndonopoulosG Giannopoulos

❮ Previous
Next ❯

Citations

Oct 24, 2009·Rheumatology International·Paola Sabrina BuonuomoAlberto G Ugazio
Jan 21, 2011·Rheumatology International·Nazife Sule Yasar BilgeCengiz Korkmaz
Oct 22, 2009·Pediatric Nephrology : Journal of the International Pediatric Nephrology Association·Ashima Gulati, Arvind Bagga
Mar 29, 2012·Pediatric Nephrology : Journal of the International Pediatric Nephrology Association·Kjell Tullus
Apr 25, 2006·Clinical Rheumatology·Zaharenia Th KarageorgakiFotini N Skopouli
Apr 1, 2006·Clinical Rheumatology·Mittermayer B Santiago, Otávio Paz
Mar 3, 2007·Clinical Rheumatology·Samuel K ShinjoMaurício Levy-Neto
Jun 22, 2012·Modern Rheumatology·Yoshiro HoraiAtsushi Kawakami
Apr 1, 2009·Japanese Journal of Ophthalmology·Kazuhisa SugiyamaKoichi Shimizu
Nov 2, 2011·Internal and Emergency Medicine·Mariagrazia CatanosoCarlo Salvarani
Feb 20, 2007·Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology·Elina JerschowDavid Rosenstreich
Jun 1, 2005·Reumatología clinica·J VicenteA Herrera
Mar 8, 2008·Cardiology in the Young·Oliver R TannMark C K Hamilton
May 29, 2008·Nature Clinical Practice. Rheumatology·Carol A Langford
Jul 3, 2010·Nature Reviews. Rheumatology·Justin C Mason
Jun 22, 2010·Rheumatology·Juergen BrunnerSusanne M Benseler
Nov 15, 2011·Rheumatology·Carlo SalvaraniLuigi Boiardi
Jan 10, 2012·Rheumatology·Arsène MekinianUNKNOWN Club Rhumatismes et Inflammation, French Vasculitis Study Group and Société Nationale Française de Médecine Interne
Dec 18, 2004·Current Opinion in Rheumatology·Patrick Liang, Gary S Hoffman
Nov 15, 2013·Current Opinion in Rheumatology·Alison Clifford, Gary S Hoffman
Dec 17, 2008·Current Opinion in Rheumatology·Sharon A Chung, Philip Seo
May 5, 2009·Current Opinion in Rheumatology·Despina EleftheriouPaul A Brogan
Oct 14, 2009·Current Opinion in Rheumatology·Alexandra Villa-ForteUNKNOWN European Vasculitis Study Group
Nov 18, 2011·Current Opinion in Rheumatology·Valentin S Schäfer, Jochen Zwerina
Jan 3, 2014·International Journal of Rheumatic Diseases·Ruchika GoelGeorge Joseph
Oct 14, 2006·Annals of the Rheumatic Diseases·D E FurstM H Weisman
Nov 21, 2007·Annals of the Rheumatic Diseases·D E FurstM E Weinblatt
Jan 1, 2009·BMJ Case Reports·Sohail AshrafAbdulrahman Alrobayan
Jun 11, 2008·Circulation·Heather L Gornik, Mark A Creager
Feb 13, 2013·Pediatric Rheumatology Online Journal·Shaun MohanKathryn S Torok
Feb 4, 2011·Pediatric Rheumatology Online Journal·Kimberly A MorishitaPaul A Brogan
Mar 21, 2008·Journal of Medical Case Reports·Nasser E DaryaniMehrdad Azmi
Nov 6, 2009·Arthritis Research & Therapy·Frank MoosigWolfgang L Gross
Feb 4, 2012·Circulation Journal : Official Journal of the Japanese Circulation Society·Hirokazu OhigashiMitsuaki Isobe
Dec 7, 2013·International Heart Journal·Yoshikazu NakaokaIssei Komuro
Jan 1, 2011·International Journal of Clinical Rheumatology·Charles F Henderson, Philip Seo

❮ Previous
Next ❯

Related Concepts

Related Feeds

Aortic Coarctation

Aortic coarctation is a congenital condition characterized by narrowing of the aorta. Discover the latest research on this disease here.

Anti-inflammatory Treatments

A drug or substance that reduces inflammation (redness, swelling, and pain) in the body. Anti-inflammatory agents block certain substances in the body that cause inflammation and swelling. Discover the latest research on anti-inflammatory treatments here

Related Papers

The New England Journal of Medicine
Wegener's Granulomatosis Etanercept Trial (WGET) Research Group
Clinical Rheumatology
Zaharenia Th KarageorgakiFotini N Skopouli
Rheumatology
Arsène MekinianClub Rhumatismes et Inflammation, French Vasculitis Study Group and Société Nationale Française de Médecine Interne
© 2022 Meta ULC. All rights reserved